Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Nebraska. Pick another state for the same tag.
Against expectation — 2025
Nebraska cites F756 more often than its own record predicts
Versus expected share1.23×
1.23 times the share F756 takes of citations nationally.
Share of Nebraska citations0.97%
Of every deficiency written in Nebraska in 2025, this is the portion that was F756.
Nebraska0.97%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Nebraska surveyors wrote
F756 findings written in Nebraska, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
G · Actual harm, isolatedNovember 7, 2018
LICENSURE REFERENCE NUMBER 175 NAC 12-006.12B(5)
Based on interview and record review, the consultant RPh (registered pharmacist) failed to identify the irregularity of [MEDICATION(S)] (a medication used to treat psychotic disorders) being administered for non-psychotic disorders (anxiety disorder and Alzheimer's disease) to Residents 15 and 26 and failed to ensure Resident 11's medical record was updated to reflect current allergies. This affected 3 of 5 residents sampled. The facility identified a census of 42 at the time of survey.
Findings are:
A. Review of Resident 15's diagnoses revealed active diagnoses of Alzheimer's Disease and Anxiety disorder. …
E · No harm, potential for more than minimal, patternJuly 27, 2026
Based on record review and interview, the facility failed to ensure the medical provider followed up on monthly medication reviews for 5 (Resident 3, 5, 6, 8, 34 and 61) of 5 sampled residents. The facility identified a census of 67. Findings are:Review of facility policy Medication Regimen Review (MRR) dated 08/01/2023 and revised date 05/06/2026 revealed the pharmacist shall document, either manually or electronically, that each medication regimen review has been completed. Further review of the MRR policy revealed the pharmacist does not need to document a continuing irregularity in the report each month of the attending physician has documented a valid clinical rationale for rejecting the pharmacist's recommendation.
A. …
C · No harm, potential for minimal, widespreadDecember 17, 2024
Licensure Reference Number 175 NAC 12-006.12(A)(vi)
Based on record review and interview the facility failed to ensure the facility's Medication Regimen Review (MRR) Policy included the required procedural steps.
Findings are:
A record review of the facility MRR policy dated 1/1/2023 revealed the following:
Policy Explanation and Compliance Guidelines:
-1. The nurses should review and follow-up on recommendations from Pharmacist's (a healthcare professional who is an expert in the science and use of medications) Admission Regimen Review (a process that involves evaluation a patient's current medications to identify potential issues).
-2. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction